Charles River eyes $35M in cuts; Frontage expands its footprint;

> Charles River Laboratories ($CRL) is looking to cut about $35 million in costs from its animal model business, implementing new technologies to make its banner segment more efficient. News

> CRO Frontage has opened a new clinical research outpost in Secaucus, NJ, offering Phase II-IV services. More

> Theorem Clinical Research has recruited Icon ($ICLR) and Quintiles ($Q) veteran Scott Treiber to lead biopharma development as executive vice president. Item

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.